A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Apollo Therapeutics Ltd
Study ID
NCT07599813
Phase
PHASE2
Status
Recruiting

Conditions

  • Atopic
  • Atopic Dermatitis
  • Dermatitis
  • Dermatitis, Atopic
  • Dermatologic Disease
  • Eczema
  • Eczema Atopic Dermatitis
  • Eczema, Atopic

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Camoteskimab — DRUG
    Drug Product
  • Placebo — DRUG
    Inactive substance

Study Details

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Key Dates

Start date
May 28, 2026
Status verified
May 2026
Primary completion
Oct 31, 2027
Completion
Apr 30, 2028

Study Design

Enrollment
280 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Dose 1
    Camoteskimab administered subcutaneously
  • Experimental: Dose 2
    Camoteskimab administered subcutaneously
  • Experimental: Dose 3
    Camoteskimab administered subcutaneously
  • Placebo Comparator: Placebo
    Dummy version of the study drug administered subcutaneously

Primary Outcome Measure

Percentage change from baseline in Eczema Area and Severity Index (EASI) between camoteskimab and placebo at Week 24 [ Time Frame: From Baseline visit until Week 24 visit ]

Locations (33)

FacilityCityStateZIPSite coordinators
AllerVie Clinical ResearchBirminghamAlabama35209-
Cahaba Dermatology and Skin Health CenterBirminghamAlabama35244-
Saguaro Dermatology AssociatesPhoenixArizona85018-
Dermatology Trial Associates, IncBryantArkansas72022-
Marvel Research, LLCHuntington BeachCalifornia92648-
Dermatology Research AssociatesLos AngelesCalifornia90048-
Metropolis DermatologyLos AngelesCalifornia90025-
University of California Los AngelesLos AngelesCalifornia90095-
Northridge Clinical TrialsNorthridgeCalifornia91325
Navid Ezra
818-350-7483
Integrative Skin Science and ResearchSacramentoCalifornia95815
Raja Sivamani
916-524-1216
Valiance Clinical Research - TarzanaTarzanaCalifornia91356-
Paradigm Clinical Research Centers, LLC: Wheat RidgeWheat RidgeColorado80033-
ABMED Clinical Research Corp.Cape CoralFlorida33904-
International Dermatology Research, INCHollywoodFlorida33021-
FXM Clinical Research Miami, LLCMiamiFlorida33155-
Quality Care Clinical ResearchMiamiFlorida33101-
Eminent Clinical Research and AssociatesNorth LauderdaleFlorida33068-
Ziaderm Research LLCNorth Miami BeachFlorida33162-
NMC Research LLCTampaFlorida33614-
Elligo - Georgia Skin & Cancer Clinic (Sidney P. Smith, MD, PC)SavannahGeorgia31406-
Ada West Research, LLCMeridianIdaho83646
Mark Schwendiman
208-884-3376
Endeavor HealthSkokieIllinois60077-
DS Research of Southern Indiana,LLCClarksvilleIndiana47129
Megan Vissing
812-213-9769
Dawes Fretzin Clinical Research Group, LLCColumbusIndiana47201-
Chesapeake Clinical Research, IncPasadenaMaryland21122-
Skin Cancer and Dermatology InstituteRenoNevada89509
Michael Heaphy
775-324-0699
Trail HorizonCliftonNew Jersey07013-
Sadick Research Group, LLCNew YorkNew York10021
Sadick
212-772-7242
Red River Research Partners, LLCFargoNorth Dakota58103-
ClinOhio Research ServicesColumbusOhio43213
Benjamin Bogucki
614-863-3222
Best Skin Research, LLCCamp HillPennsylvania17011
Steven Schleicher
570-459-0029
UPMC Department of DermatologyPittsburghPennsylvania15213-
Progressive Clinical Research, PASan AntonioTexas78213
Mark Lee
210-614-5557

Find similar trials in Birmingham, AL

Related Studies